发明授权
US07297793B2 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
失效
双磺酰胺羟乙基氨基酸逆转录病毒蛋白酶抑制剂
- 专利标题: Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
- 专利标题(中): 双磺酰胺羟乙基氨基酸逆转录病毒蛋白酶抑制剂
-
申请号: US11349352申请日: 2006-02-08
-
公开(公告)号: US07297793B2公开(公告)日: 2007-11-20
- 发明人: John N. Freskos , Daniel P. Getman , John J. Talley , James A. Sikorski
- 申请人: John N. Freskos , Daniel P. Getman , John J. Talley , James A. Sikorski
- 申请人地址: US IL Chicago
- 专利权人: G.D. Searle, LLC
- 当前专利权人: G.D. Searle, LLC
- 当前专利权人地址: US IL Chicago
- 代理机构: Banner & Witcoff Ltd.
- 主分类号: C07D295/26
- IPC分类号: C07D295/26 ; C07D413/12 ; C07D401/14 ; C07D401/12
摘要:
Bis-sulfonamido hydroxyethylamino compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to retroviral protease inhibiting compounds of the formula: or a pharmaceutically acceptable salt, prodrug or ester thereof, wherein the variables are as defined herein.
公开/授权文献
信息查询